HOYA SURGICAL OPTICS ANNOUNCES FDA APPROVAL OF CLEAR OPTIC IOL’S FOR THE US MARKET

April 21, 2012

CHINO HILLS, CA, APRIL, 2012 – HOYA Surgical Optics, Inc. (HSO) announced today that they have received approval from the FDA to commercially distribute two models of clear foldable hydrophobic acrylic‐optic aspheric intraocular lenses; the iSymm™ Intraocular Lens (Model FC‐60AD) and the preloaded iSert™ Intraocular Lens (Model PC‐60AD) in the U.S.

HOYA Surgical Optics is focused on helping ophthalmic surgeons confidently build their premium practices and believes that every patient is a premium patient. These lenses are an important addition to HSO’s line of foldable and pre‐loaded IOL’s available with the Optimized Aspheric™ design. Jake Vander Zanden, President, Americas stated “HOYA Surgical Optics remains strongly committed to our U.S. customers and delivering on this new direction in refractive cataract surgery. Our COMPLETE SYSTEM™ uses the HOYA iTrace® Surgical Workstation with advanced wavefront diagnostics to assist surgeons in the proper selection of an IOL, based on the patient’s specific optical system.”

This approval is another first in the US ophthalmology marketplace. HOYA Surgical Optics is the only company offering both UV Absorbing (clear) and Blue Light Filtering (yellow) IOL’s in preloaded and cartridge style configurations. Any customers in need of assistance are asked to contact their Sales Representative or call Hoya Surgical Optics Customer Service toll‐free at 866‐750‐5870.

About HOYA Surgical Optics
HOYA Surgical Optics is a leading global ophthalmic device company with an entrepreneurial spirit focused on what matters most to realize both exceptional patient outcomes and better practice results. Leveraging more than 70 years of excellence in optics design and innovation that has been the hallmark of the HOYA Corporation, HOYA Surgical Optics provides ophthalmologists with innovative ophthalmic devices and services in key strategic segments that help them elevate their quality of care and business efficiencies.

All statements in this press release that are not statements of historical fact are forward‐looking statements, including statements about any of the following: the plans, strategies, and objectives of management for future operations or prospects for achieving such plans; our future performance statement of belief, and any statements of assumptions underlying any of the foregoing.